Manufacturer record
Manfriday Lifesciences Khewat no. 17/10: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Manfriday Lifesciences Khewat no. 17/10 (Haryana) were declared Not of Standard Quality between July 2025 and July 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Manfriday Lifesciences Khewat no. 17/10 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paroxetine Hydrochloride Prolonged Release Tablets IP 25mg (Pexitalk CR-25 Tablets) | MFT-250501Mfg 2025-05 · Exp 2027-04 | Assay of Paroxetine Hydrochloride Hemihydrate calculated as ParoxetineAssay | RDTL, ChandigarhCDSCO lab | Jul 2025 |
| Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup (BRONCHITY-DX) | MFL-250501Mfg 2025-05 · Exp 2027-04 | Assay of Dextromethorphan Hydrobromide, Phenylephrine HydrochlorideAssay | RDTL, ChandigarhCDSCO lab | Jul 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.